Full Press Release Details
Xtant Medical To Present at ICV Manhattan
BELGRADE, Mont., DEC. 3, 2015
(GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT: XTNT), formerly Bacterin International Holdings, Inc., a leader in
the development of class-leading regenerative medicine products and medical devices, today announced that its Chief Financial Officer,
John Gandolfo, will present at the ICV Manhattan Conference, to be held December 8 & 9th, 2015 at the Mandarin Oriental New
York. Xtant Medical's presentation will take place Tuesday, December 8, 2015 at 9:45 AM Eastern Time.
About Xtant Medical Holdings
Xtant Medical Holdings,
Inc. (NYSE MKT: XTNT) develops, manufactures and markets class-leading regenerative medicine products and medical devices for domestic
and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics
for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment
of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. With core competencies in
both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological
and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.
Important Cautions Regarding Forward-looking
This press release contains certain
disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive
in nature, that depend upon or refer to future events or conditions, or that include words such as "continue," "efforts,"
"expects," "anticipates," "intends," "plans," "believes," "estimates,"
"projects," "forecasts," "strategy," "will," "goal," "target," "prospects,"
"potential," "optimistic," "confident," "likely," "probable" or similar expressions
or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these
statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of
important factors, including, among others: the Company's ability to successfully integrate the acquisition of X-spine; the ability
of the Company's sales force to achieve expected results, the Company's ability to meet its existing and anticipated contractual
obligations, including financial covenant and other obligations contained in the Company's secured lending facility; the Company's
ability to manage cash flow; the Company's ability to develop, market, sell and distribute desirable applications, products and
services and to protect its intellectual property; the ability of the Company's customers to pay and the timeliness of such payments;
the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability
to attract and retain management and employees with appropriate skills and expertise; the impact of changes in market, legal and
regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. Additional
risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk
Factors." The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.